跳至主要内容
临床试验/CTRI/2022/02/040005
CTRI/2022/02/040005尚未招募2 期

Preclinical and clinical evaluation of Siddha drug Veppampoo Mathirai in uraththa pitha vaatham - Systemic Hypertension

Self1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2022年10月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
31
试验地点
1
主要终点
Outcome assessed by an expected reduction in blood pressure value of systolic 10-20mmHg and diastolic 5-15mmHg.

研究概览

简要总结

This is an open clinical interventional evaluation of Siddha drug Veppampoo Mathirai for Systemic Hypertension. Both gender of age 18-60 will be enrolled based on inclusion and exclusion criteria. Intervention will be given for 60 days and the outcome is assessed on the basis of systolic, diastolic and mean arterial pressure before and after treatment.

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed systemic Hypertension patients having blood pressure value systolic 140-179mmHg and diastolic 90-109mmHg, willing to give written consent to participate in the study.

排除标准

  • Blood pressure value having systolic greater or equal to 180mmHg and diastolic greater or equal to 110mmHg, Secondary hypertension, Diabetes mellitus, cardiovascular disease/ hepatic disease, asthmatic and copd patients, pregnant women and lactating mothers, patients who are on steroids, oral contraceptive pills, oestrogen replacement therapy.participants will be excluded clinically or based on available medical reports.

结局指标

主要结局

Outcome assessed by an expected reduction in blood pressure value of systolic 10-20mmHg and diastolic 5-15mmHg.

时间窗: 0 day and 61 day

次要结局

  • Liver and renal parameters compared before and after treatment.(0 day and 61 day)

研究者

发起方
Self
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

Siddha drug veppampoo Mathirai for Blood pressure | 临床试验